Heat stable Carbetocin Versus Oxytocin for active management of third stage of labour at Federal Medical Center Bida: A randomised controlled trial.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202504851520771

Enrollment

108

Registered

2025-04-29

Start date

2025-03-17

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth Primary Postpartum Haemorrhage

Interventions

Active management of third stage of labour using Oxytocin

Active management of third stage of labour with 100mcg heat Stable Carbetocin

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: All consenting pregnant women after the age of viability having vaginal delivery

Exclusion criteria

Exclusion criteria: Cardiac disease in pregnancy Anaemia in pregnancy Allergies to oxytocin or Carbetocin Multiple gestation Polyhydramnios

Design outcomes

Primary

Measure	Time frame
1. Blood loss >/= 500ml	—

Secondary

Measure	Time frame
Need for additional uterotonics, need for blood transfusion, duration of third stage of labour	—

Countries

Nigeria

Contacts

Public ContactFatima Gbate

Senior Registra

ummuakeel@gmail.com+1248036897929

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026